Dec

5

NPR Series Examines Use, Ethics Of Preimplantation Genetic Diagnosis For Embryonic Disease Screening, Sex Selection

December 5, 2009 | |

NPR’s “All Things Considered” on Wednesday included three reports on the use of preimplantation genetic diagnosis to screen embryos. Summaries of the segments figure lower.

  • The first segment profiles Jenifer and Angelo Magliocco, whose first son died of a rare genetic disease at eight weeks old. The couple used PGD to select an embryo to implant for their next pregnancy without the gene for the condition. The segment includes comments from the Maglioccos; Chad Kingsbury, who used PGD to screen embryos for a family susceptibility to colon cancer; and Dagan Wells, a geneticist at Yale University (Palca, “All Things Considered,” NPR, 12/20). Audio of the segment is available online.

  • The second segment examines couples’ use of PGD to select embryos by sex. The segment includes comments from Sujatha Jesudason, program director at the Center for Genetics and Society; Daniel Potter, a reproductive specialist at Huntington Reproductive Center; and an Indian couple who visited Potter to select a male embryo (Shavelson, “All Things Considered,” NPR, 12/20). Audio of the segment is available online.

  • The final segment includes an interview with Eric Cohen, director of the Bioethics and American Democracy Program at the Ethics and Public Policy Center, about the ethical issues involved in PGD for embryo selection (Norris, “All Things Considered,” NPR, 12/20). Audio of the segment is available online.

“Reprinted with permission from http://www.kaisernetwork.org. You can projection the entire Kaiser Daily Health Policy Relate, search the archives, or sign up for email delivery at http://www.kaisernetwork.org/dailyreports/healthpolicy. The Kaiser Every day Health Policy Report is published for kaisernetwork.org, a unused service of The Henry J. Kaiser Genealogy Fundamental . © 2005 Admonitory Board Company and Kaiser Family Purpose. All rights reserved.


Comments



You must be logged in to post a comment.

Name (required)

Email (required)

Website

Speak your mind